A
Addex Therapeutics Ltd (ADXN)
NCM – Real Time Price. Currency in USD
6.70
-0.16 (-2.33%)
At close: May 12, 2026, 4:00 PM EDT
6.58
-0.28 (-4.08%)
After-hours: May 12, 2026, 4:04 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
6.70
-0.16 (-2.33%)
At close: May 12, 2026, 4:00 PM EDT
6.58
-0.28 (-4.08%)
After-hours: May 12, 2026, 4:04 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.40 | 6.05 | 7.0 | |
| Quick ratio | 1.40 | 5.63 | 7.0 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | -1355.25 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2M | 2M | 466K | 208K | 205K |
| Gross Profit | N/A | N/A | 170K | 198K | 118K |
| Operating Income | -21M | -2M | -3M | -3M | -3M |
| Net Income | -22M | -12M | 8M | -8M | -8M |
| EBITDA | -21M | -2M | -3M | -3M | -3M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | -100 | 31.77 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -68.03 | -16.6 | 50.33 | -11.35 | 3.3 |
| Y/Y | 1052.42 | -67.25 | 44.21 | -482.29 | 5.5 |
| 3y average | -36.81 | 4.39 | 54.47 | 45.6 | 6.3 |
| 5y average | -36.07 | -7.81 | 27.79 | 21.32 | 5.5 |
| Weighted average score | 5.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $2.1M significantly exceed its total debt $43.8K, ensuring strong financial flexibility
Total current assets $2.1M exceed Total current liabilities $1.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-1,355.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$767.1K limits the company's ability to reinvest or pay down debt